Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2602-2609

  Chen, Neng ^a   Pinsky, Benjamin A ^a   Lee, Betty P ^b   Lin, Min ^c   Schrijver, Iris ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c FLUIDIGM CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; HISTIDINE; OSELTAMIVIR; TYROSINE; VIRUS SIALIDASE;

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; HUMAN; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEIC ACID ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; RARE VARIANT SENSITIVE HIGH RESOLUTION MELTING CURVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THROAT CULTURE; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; OSELTAMIVIR; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TRANSITION TEMPERATURE;

INFLUENZA A VIRUS;

EID: 79959835601     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00277-11     Document Type: Article

References (18)

1. de Jong, M. D., et al. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353:2667-2672.
2. Deyde, V. M., et al. 2010. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 54:1102-1110.
3. Dharan, N. J., et al. 2009. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 301:1034-1041.
4. Do, H., and A. Dobrovic. 2009. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies. Mol. Cancer 8:82.
5. Fuster, O., et al. 2009. Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis. J. Mol. Diagn. 11:458-463.
6. Gubareva, L. V., L. Kaiser, M. N. Matrosovich, Y. Soo-Hoo, and F. G. Hayden. 2001. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183:523-531.
7. Hindiyeh, M., et al. 2010. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR. J. Clin. Microbiol. 48:1884-1887.
8. Krypuy, M., et al. 2007. High-resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 7:168.
9. Lackenby, A., et al. 2008. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro Surveill. 13(5):pii=8026. http://www.eurosurveillance.org/images/dynamic/EE/V13N05/art8026.pdf.
10. Metzker, M. L. 2010. Sequencing technologies: the next generation. Nat. Rev. Genet. 11:31-46.
11. Ogino, S., et al. 2005. Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J. Mol. Diagn. 7:413-421.
12. Operario, D. J., M. J. Moser, and K. St. George. 2010. Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus. J. Clin. Microbiol. 48:3517-3524.
13. Palese, P., and R. W. Compans. 1976. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J. Gen. Virol. 33:159-163.
14. Renaud, C., J. Kuypers, and L. Corey. 2010. Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus. J. Clin. Virol. 49:21-25.
15. van der Vries, E., et al. 2010. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 47:34-37.
16. World Health Organization. 2008. Influenza A(H1N1) virus resistance to oseltamivir. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/influenza/h1n1 table/en/.
17. World Health Organization. 2006. Rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/ disease/avian/influenza/guidelines/pharmamanagement/en/index.html.
18. World Health Organization. 2010. Weekly update on oseltamivir resistance to influenza A (H1N1) 2009 viruses. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/swineflu/ oseltamivirresistant20100820.pdf.